[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

May 2019 | 555 pages | ID: TA7F25174A7EN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019' provides an overview of Transdermal Drug Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Transdermal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Transdermal Drug Delivery Devices Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
3.2 Transdermal Drug Delivery Devices - Pipeline Products by Segment
3.3 Transdermal Drug Delivery Devices - Pipeline Products by Territory
3.4 Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
3.5 Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Transdermal Drug Delivery Devices - Ongoing Clinical Trials

4 TRANSDERMAL DRUG DELIVERY DEVICES - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
4.2 Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development

5 TRANSDERMAL DRUG DELIVERY DEVICES COMPANIES AND PRODUCT OVERVIEW

5.1 3M Co Company Overview
5.2 4P Therapeutics LLC Company Overview
5.3 Actuated Medical Inc Company Overview
5.4 Aequus Pharmaceuticals Inc Company Overview
5.5 Agile Therapeutics Inc Company Overview
5.6 Allergan Plc Company Overview
5.7 Alliqua BioMedical Inc Company Overview
5.8 AMW GmbH Company Overview
5.9 AngioSoma Inc Company Overview
5.10 Apogee Technology Inc Company Overview
5.11 Asahi Kasei Pharma Corp Company Overview
5.12 AstraZeneca Plc Company Overview
5.13 Avro Life Sciences Company Overview
5.14 Boryung Pharmaceutical Co Ltd Company Overview
5.15 Burke Pharmaceuticals LLC Company Overview
5.16 Cassava Sciences Inc Company Overview
5.17 CB Scientific Inc Company Overview
5.18 Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview
5.19 ChemioCare USA Inc Company Overview
5.20 Chrono Therapeutics Inc Company Overview
5.21 Cipla Ltd Company Overview
5.22 Clexio Biosciences Ltd Company Overview
5.23 Corium International Inc Company Overview
5.24 Daewoong Pharmaceutical Co Ltd Company Overview
5.25 DBV Technologies SA Company Overview
5.26 DD Therapeutics LLC Company Overview
5.27 Dermisonics Inc (Inactive) Company Overview
5.28 Dharma Therapeutics, Inc. (Inactive) Company Overview
5.29 Drexel University Company Overview
5.30 DURECT Corp Company Overview
5.31 Echo Therapeutics Inc Company Overview
5.32 Emplicure AB Company Overview
5.33 Endo International Plc Company Overview
5.34 Extend Biosciences Inc Company Overview
5.35 Fe3 Medical Inc Company Overview
5.36 Georgia Institute of Technology Company Overview
5.37 Georgia State University Company Overview
5.38 Hisamitsu Pharmaceutical Co Inc Company Overview
5.39 I.M. Sechenov Moscow State Medical University Company Overview
5.40 Icure Pharmaceutical Inc Company Overview
5.41 ImmuPatch Company Overview
5.42 Indian Institute of Science Company Overview
5.43 Indian Institute of Technology Bombay Company Overview
5.44 InMed Pharmaceuticals Inc Company Overview
5.45 Institute of Materials Research & Engineering Company Overview
5.46 Intercell AG (Inactive) Company Overview
5.47 Interstitial NS Company Overview
5.48 Isis Biopolymer Inc (Inactive) Company Overview
5.49 Janisys Company Overview
5.50 KTH Royal Institute of Technology Company Overview
5.51 LEO Pharma A/S Company Overview
5.52 Lohmann Therapie-Systeme AG Company Overview
5.53 Luye Pharma Group Ltd Company Overview
5.54 Massachusetts Institute of Technology Company Overview
5.55 Mayne Pharma Group Ltd Company Overview
5.56 Medherant Ltd Company Overview
5.57 Medifron DBT Inc Company Overview
5.58 MEDRx Co Ltd Company Overview
5.59 MedRx, Inc. Company Overview
5.60 Microdermics Inc Company Overview
5.61 Micron Biomedical Inc Company Overview
5.62 Micropoint Technologies Pte Ltd Company Overview
5.63 National University of Singapore Company Overview
5.64 Nemaura Pharma Ltd Company Overview
5.65 NeuroDerm Ltd Company Overview
5.66 Nitto Denko Corp Company Overview
5.67 North Carolina State University Company Overview
5.68 Noven Pharmaceuticals Inc Company Overview
5.69 NutriBand Inc Company Overview
5.70 Nuvo Pharmaceuticals Inc Company Overview
5.71 Phosphagenics Ltd Company Overview
5.72 Prometheon Pharma LLC Company Overview
5.73 Purdue University Company Overview
5.74 Radius Health Inc Company Overview
5.75 Scilex Ltd Company Overview
5.76 Seelos Therapeutics Inc Company Overview
5.77 Shenox Pharmaceuticals LLC Company Overview
5.78 Sinsin Pharmaceutical Co Ltd Company Overview
5.79 Skinject Inc Company Overview
5.80 Sparsha Pharma International Pvt Ltd Company Overview
5.81 Sparsha Pharma USA Inc Company Overview
5.82 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.83 Stanford University Company Overview
5.84 Sumitomo Dainippon Pharma Co Ltd Company Overview
5.85 Syntropharma Ltd Company Overview
5.86 Taho Pharmaceuticals Ltd Company Overview
5.87 Teikoku Pharma USA Inc Company Overview
5.88 tesa Labtec GmbH Company Overview
5.89 Teva Pharmaceutical Industries Ltd Company Overview
5.90 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview
5.91 TheraJect Inc Company Overview
5.92 Therapeutic Systems Research Laboratories Inc Company Overview
5.93 TheraSolve NV Company Overview
5.94 Theratech, Inc. Company Overview
5.95 Thrudermic LLC Company Overview
5.96 Titan Pharmaceuticals Inc Company Overview
5.97 Toa Eiyo Ltd Company Overview
5.98 Transcu Group Limited (Inactive) Company Overview
5.99 Transdermal Delivery Solutions Corp Company Overview
5.100 Transdermal Specialties Inc Company Overview
5.101 TransPharma Medical Ltd (Inactive) Company Overview
5.102 Transport Pharmaceuticals Inc Company Overview
5.103 Univec, Inc. (Inactive) Company Overview
5.104 University of Illinois at Chicago Company Overview
5.105 University of North Carolina at Chapel Hill School of Medicine Company Overview
5.106 University of Toronto Company Overview
5.107 ViiV Healthcare UK Ltd Company Overview
5.108 Vyteris, Inc. (Inactive) Company Overview
5.109 Xel Pharmaceuticals Inc Company Overview
5.110 Zambon Italia Srl Company Overview
5.111 Z-Cube Srl Company Overview
5.112 ZetrOZ, Inc. Company Overview
5.113 Zosano Pharma Corp Company Overview
5.114 Zynerba Pharmaceuticals Inc Company Overview

6 TRANSDERMAL DRUG DELIVERY DEVICES - RECENT DEVELOPMENTS

6.1 Apr 29, 2019: ChemioCare announces appointment of Roy F. Waldron to its board of directors
6.2 Apr 25, 2019: 3M reports first-quarter 2019 results; company initiates restructuring
6.3 Apr 25, 2019: The Medicines Company reports first-quarter 2019 financial results and significant progress with the Inclisiran clinical development program
6.4 Apr 25, 2019: DURECT appoints two new board members
6.5 Apr 22, 2019: KalVista Pharmaceuticals names Daniel B. Soland to board of directors
6.6 Apr 19, 2019: Alvogen issues voluntary nationwide recall of Fentanyl Transdermal System due to product mislabeling
6.7 Apr 11, 2019: Sumitomo Dainippon Pharma announces mid-term business plan 2022
6.8 Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving credit facility
6.9 Apr 09, 2019: Revance appoints former Allergan marketing veteran Taryn Conway as Vice President of marketing
6.10 Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
Table 2: Transdermal Drug Delivery Devices - Pipeline Products by Segment
Table 3: Transdermal Drug Delivery Devices - Pipeline Products by Territory
Table 4: Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
Table 5: Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
Table 6: Transdermal Drug Delivery Devices - Ongoing Clinical Trials
Table 7: Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
Table 8: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
Table 9: 3M Co Pipeline Products & Ongoing Clinical Trials Overview
Table 10: 3M Hollow Microstructured Transdermal System - Product Status
Table 11: 3M Hollow Microstructured Transdermal System - Product Description
Table 12: 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: 4P Clonidine Transdermal Patch - Product Status
Table 14: 4P Clonidine Transdermal Patch - Product Description
Table 15: 4P Scopolamine Transdermal Patch - Product Status
Table 16: 4P Scopolamine Transdermal Patch - Product Description
Table 17: Defent - Product Status
Table 18: Defent - Product Description
Table 19: Passive Transdermal Lidocaine Patch - Product Status
Table 20: Passive Transdermal Lidocaine Patch - Product Description
Table 21: Passive Transdermal Patch - Product Status
Table 22: Passive Transdermal Patch - Product Description
Table 23: Transdermal Apomorphine Patch - Product Status
Table 24: Transdermal Apomorphine Patch - Product Description
Table 25: Transdermal Exenatide Patch - Product Status
Table 26: Transdermal Exenatide Patch - Product Description
Table 27: Transdermal FSH Patch - Product Status
Table 28: Transdermal FSH Patch - Product Description
Table 29: Transdermal Patch - Diabetes - Product Status
Table 30: Transdermal Patch - Diabetes - Product Description
Table 31: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 32: GentleDispense System - Product Status
Table 33: GentleDispense System - Product Description
Table 34: Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: AQS1301 - Product Status
Table 36: AQS1301 - Product Description
Table 37: AQS1302 - Product Status
Table 38: AQS1302 - Product Description
Table 39: AQS1303 - Product Status
Table 40: AQS1303 - Product Description
Table 41: AQS1304 - Product Status
Table 42: AQS1304 - Product Description
Table 43: Aequus Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 44: AQS1301 - Phase Ia Study of AQS-1301 in Healthy Subjects
Table 45: Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: AG200-ER Patch - Product Status
Table 47: AG200-ER Patch - Product Description
Table 48: AG200-SP Patch - Product Status
Table 49: AG200-SP Patch - Product Description
Table 50: AG890 Patch - Product Status
Table 51: AG890 Patch - Product Description
Table 52: Twirla (AG200-15) - Product Status
Table 53: Twirla (AG200-15) - Product Description
Table 54: Agile Therapeutics Inc - Ongoing Clinical Trials Overview
Table 55: Twirla (AG200-15) - Assessing Adhesion with Transdermal and Topical Delivery Systems for ANDAs
Table 56: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Nanotechnology-Based Transdermal Delivery System - Product Status
Table 58: Nanotechnology-Based Transdermal Delivery System - Product Description
Table 59: Norethindrone Transdermal Delivery System - Product Status
Table 60: Norethindrone Transdermal Delivery System - Product Description

LIST OF FIGURES

Figure 1: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
Figure 2: Transdermal Drug Delivery Devices - Pipeline Products by Segment
Figure 3: Transdermal Drug Delivery Devices - Pipeline Products by Territory
Figure 4: Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
Figure 5: Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Transdermal Drug Delivery Devices - Ongoing Clinical Trials

COMPANIES MENTIONED

3M Co
4P Therapeutics LLC
Actuated Medical Inc
Aequus Pharmaceuticals Inc
Agile Therapeutics Inc
Allergan Plc
Alliqua BioMedical Inc
AMW GmbH
AngioSoma Inc
Apogee Technology Inc
Asahi Kasei Pharma Corp
AstraZeneca Plc
Avro Life Sciences
Boryung Pharmaceutical Co Ltd
Burke Pharmaceuticals LLC
Cassava Sciences Inc
CB Scientific Inc
Cerimon Pharmaceuticals, Inc.
ChemioCare USA Inc
Chrono Therapeutics Inc
Cipla Ltd
Clexio Biosciences Ltd
Corium International Inc
Daewoong Pharmaceutical Co Ltd
DBV Technologies SA
DD Therapeutics LLC
Dermisonics Inc
Dharma Therapeutics, Inc.
Drexel University
DURECT Corp
Echo Therapeutics Inc
Emplicure AB
Endo International Plc
Extend Biosciences Inc
Fe3 Medical Inc
Georgia Institute of Technology
Georgia State University
Hisamitsu Pharmaceutical Co Inc
I.M. Sechenov Moscow State Medical University
Icure Pharmaceutical Inc
ImmuPatch
Indian Institute of Science
Indian Institute of Technology Bombay
InMed Pharmaceuticals Inc
Institute of Materials Research & Engineering
Intercell AG
Interstitial NS
Isis Biopolymer Inc
Janisys
KTH Royal Institute of Technology
LEO Pharma A/S
Lohmann Therapie-Systeme AG
Luye Pharma Group Ltd
Massachusetts Institute of Technology
Mayne Pharma Group Ltd
Medherant Ltd
Medifron DBT Inc
MEDRx Co Ltd
MedRx, Inc.
Microdermics Inc
Micron Biomedical Inc
Micropoint Technologies Pte Ltd
National University of Singapore
Nemaura Pharma Ltd
NeuroDerm Ltd
Nitto Denko Corp
North Carolina State University
Noven Pharmaceuticals Inc
NutriBand Inc
Nuvo Pharmaceuticals Inc
Phosphagenics Ltd
Prometheon Pharma LLC
Purdue University
Radius Health Inc
Scilex Ltd
Seelos Therapeutics Inc
Shenox Pharmaceuticals LLC
Sinsin Pharmaceutical Co Ltd
Skinject Inc
Sparsha Pharma International Pvt Ltd
Sparsha Pharma USA Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stanford University
Sumitomo Dainippon Pharma Co Ltd
Syntropharma Ltd
Taho Pharmaceuticals Ltd
Teikoku Pharma USA Inc
tesa Labtec GmbH
Teva Pharmaceutical Industries Ltd
The Sheikh Zayed Institute for Pediatric Surgical Innovation
TheraJect Inc
Therapeutic Systems Research Laboratories Inc
TheraSolve NV
Theratech, Inc.
Thrudermic LLC
Titan Pharmaceuticals Inc
Toa Eiyo Ltd
Transcu Group Limited
Transdermal Delivery Solutions Corp
Transdermal Specialties Inc
TransPharma Medical Ltd
Transport Pharmaceuticals Inc
Univec, Inc.
University of Illinois at Chicago
University of North Carolina at Chapel Hill School of Medicine
University of Toronto
ViiV Healthcare UK Ltd
Vyteris, Inc.
Xel Pharmaceuticals Inc
Zambon Italia Srl
Z-Cube Srl
ZetrOZ, Inc.
Zosano Pharma Corp
Zynerba Pharmaceuticals Inc


More Publications